Literature DB >> 11561057

Mechanisms of induction of persistent nociception by dynorphin.

T M Laughlin1, A A Larson, G L Wilcox.   

Abstract

The opioid peptide dynorphin has been demonstrated to be both nociceptive and antinociceptive. This article will review the potential mechanisms through which dynorphin contributes to spinally mediated nociception. Specifically, we will examine the interaction of dynorphin with multiple sites on the NMDA receptor complex. Dynorphin-induced opioid activity is generally inhibitory, with a tendency to impede nociceptive signals and serve in a neuroprotective capacity. In contrast, dynorphin's interaction with multiple sites on the NMDA receptor complex produces excitatory responses resulting in nociceptive and even toxic effects. Thus, it is hypothesized that dynorphin has both physiological and pathological roles in acute and chronic pain states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561057

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

2.  Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity.

Authors:  Amina S Woods; Rafal Kaminski; Murat Oz; Yun Wang; Kurt Hauser; Robin Goody; Hay-Yan J Wang; Shelley N Jackson; Peter Zeitz; Karla P Zeitz; Dorota Zolkowska; Raf Schepers; Michael Nold; Jens Danielson; Astrid Gräslund; Vladana Vukojevic; Georgy Bakalkin; Allan Basbaum; Toni Shippenberg
Journal:  J Proteome Res       Date:  2006-04       Impact factor: 4.466

3.  Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in rats.

Authors:  Xionggang Chen; Tingting Wang; Caizhu Lin; Baihong Chen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 5.  Downstream Regulatory Element Antagonist Modulator (DREAM), a target for anti-thrombotic agents.

Authors:  Jaehyung Cho
Journal:  Pharmacol Res       Date:  2017-01-05       Impact factor: 7.658

6.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

7.  Evidence for the modulation of nociception in mice by central mast cells.

Authors:  C L Kissel; K J Kovács; A A Larson
Journal:  Eur J Pain       Date:  2017-07-19       Impact factor: 3.931

8.  Increased spinal prodynorphin gene expression in reinflammation-associated hyperalgesia after neonatal inflammatory insult.

Authors:  Jack Yu-Shih Lin; Yu-Che Cheng; Julia Yi-Ru Chen; Chih-Cheng Chien; Shih-Chang Lin; Yeong-Ray Wen; Tsung-Shan Tsou; Qing-Dong Ling
Journal:  BMC Neurosci       Date:  2010-10-25       Impact factor: 3.288

Review 9.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

10.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.